Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients

Peripheral T cell lymphoma (PTCL) is a heterogeneous group of aggressive lymphomas with poor prognosis. Elderly (age ≥ 65years) patients generally have impaired bone marrow function, altered drug metabolism, comorbidities, and poor functional status. Thus, treatment of elderly patients with relapsed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Korean Med Sci
Glavni autori: Lee, Seung-Shin, Jung, Sung-Hoon, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Cho, Min-Seok, Jung, Seung-Yeon, Lee, Je-Jung, Kim, Hyeoung-Joon, Yang, Deok-Hwan
Format: Artigo
Jezik:Inglês
Izdano: The Korean Academy of Medical Sciences 2016
Teme:
Brief Communication
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4901011/
https://ncbi.nlm.nih.gov/pubmed/27366017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.7.1160
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items